EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae

Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding iD, David A Rosen iD

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Paeton L Wantuch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri, United States of America. Hauptthemen laut MEDLINE: Vaccines, Klebsiella Infections. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Children's Discovery Institute, W. M. Keck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella pneumoniae presents as two circulating pathotypes: classical K . pneumoniae (c Kp) and hypervirulent K . pneumoniae (hv Kp ). Classical isolates are considered urgent threats due to their antibiotic resistance profiles, while hv Kp isolates have historically been antibiotic susceptible. Recently, however, increased rates of antibiotic resistance have been observed in both hv Kp and c Kp , further underscoring the need for preventive and effective immunotherapies. Two distinct surface polysaccharides have gained traction as vaccine candidates against K . pneumoniae : capsular polysaccharide and the O-antigen of lipopolysaccharide. While both targets have practical advantages and disadvantages, it remains unclear which of these antigens included in a vaccine would provide superior protection against matched K . pneumoniae strains. Here, we report the production of two bioconjugate vaccines, one targeting the K2 capsular serotype and the other targeting the O1 O-antigen. Using murine models, we investigated whether these vaccines induced specific antibody responses that recognize K2:O1 K . pneumoniae strains. While each vaccine was immunogenic in mice, both c Kp and hv Kp strains exhibited decreased O-antibody binding in the presence of capsule. Further, O1 antibodies demonstrated decreased killing in serum bactericidal assays with encapsulated strains, suggesting that the presence of K . pneumoniae capsule blocks O1-antibody binding and function. Finally, the K2 vaccine outperformed the O1 vaccine against both c Kp and hv Kp in two different murine infection models. These data suggest that capsule-based vaccines may be superior to O-antigen vaccines for targeting hv Kp and some c Kp strains, due to capsule blocking the O-antigen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinesKlebsiella InfectionsMiceAnimalsVirulenceO AntigensKlebsiella pneumoniaeLipopolysaccharidesAnti-Bacterial Agents

Substanzen

O AntigensLipopolysaccharidesVaccinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri, United States of America.
  • Omniose, Saint Louis, Missouri, United States of America.
  • National Research Council Canada, Human Health Therapeutics Centre, Ottawa, Ontario, Canada.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.

ORCID-Profile: Christian M Harding, David A Rosen

Förderung

  • NIAID NIH HHS
  • Children's Discovery Institute
  • W. M. Keck Foundation
  • Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
  • Australian Research Council

Zitieren

APA

Wantuch, P. L., Knoot, C. J., Robinson, L. S., Vinogradov, E., Scott, N. E., Harding, C. M., & Rosen, D. A. (2023). Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011367

Vancouver

Wantuch PL, Knoot CJ, Robinson LS, Vinogradov E, Scott NE, Harding CM, et al. Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011367

BibTeX
@article{Wantuch2023,
  author = {Wantuch, Paeton L and Knoot, Cory J and Robinson, Lloyd S and Vinogradov, Evgeny and Scott, Nichollas E and Harding, Christian M and Rosen, David A},
  title = {Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011367}
}
Kostenlos starten →